\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

Trovagene Company Update Wecast
 October 24, 2018
 8:30am - 9:30am EDT

Trovagene management team will provide an update on the Company's clinical development program and associated financing, key milestones, and collaboration and partnering activities.  The Webcast will take place on Wednesday, October 24th at 8:30 am EDT.  To join the conference call and webcast please click on the following link: https://services.choruscall.com/links/trov181024.html. The webcast will be available on the investor page of the Trovagene website www.trovagene.com for 90 days following the webcast presentation.